Your Article Summary
See Latest ArticlesSafety and tolerability of sirolimus treatment in patients with autosomal dominant polycystic kidney disease
Nephrology Dialysis Transplantation, 06/16/09
Serra AL et al. - Treatment of ADPKD patients with sirolimus with a dose of 1–2 mg/day is safe and does not cause proteinuria or impairment of GFR. Treatment adherence was excellent.
Related Articles
Cystic Changes of Breast in a Family With Autosomal Dominant Polycystic Kidney Disease
Iranian Journal of Kidney Diseases, 10/13/09
Relevance Score: 68%
Loss of Tsc1, but not Pten, in renal tubular cells causes polycystic kidney disease by activating mTORC1
Human Molecular Genetics, 11/03/09
Relevance Score: 67%
Autosomal Dominant Polycystic Kidney Disease: Current and Emerging Treatments
Kidney, 10/30/09
Relevance Score: 67%
Autosomal Dominant Polycystic Kidney Disease: New Treatment Options and How to Test Their Efficacy
Kidney and Blood Pressure Research, 11/06/09
Relevance Score: 66%
Psoas abscess in hemodialysis patients
International Urology and Nephrology, 10/06/09
Relevance Score: 66%
Today in Cystic Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Isolated renal hydatid cyst managed by laparoscopic transperitoneal nephrectomy
Indian Journal of Urology, 12/09/09
Mitochondrial Autophagy Promotes Cellular Injury in Nephropathic Cystinosis
Journal of the American Society of Nephrology, 12/08/09
Glomerular and proximal tubule cysts as early manifestations of Pkd1 deletion
Nephrology Dialysis Transplantation, 12/07/09